Health Economics
A Definitive Strategic Executive Paper for Healthcare Leaders, Chief Medical Officers, and Health System Operations Executive Summary: As we navigate 2026 and look toward 2027, the global healthcare ecosystem faces unprecedented operational shifts: generative AI integration…
Articles
From Government Protection to Strategic Health Financing, Insurance, Risk Pooling and Value-Based Care Executive Summary Healthcare is not governed by a single policy. It is governed by a policy architecture—a connected system of laws, regulations, financing…
Leadership
Understanding the Moroccan Healthcare Market: From Universal Coverage to a New Healthcare Economy Executive Summary Morocco is entering a defining phase in the development of its healthcare system. The country is moving beyond the traditional model…
Articles
Industry Review | MENA & Africa Healthcare Magazine | August 2026 Insurance is no longer simply a financial mechanism for transferring risk. In Egypt and Saudi Arabia, insurance is becoming an increasingly important part of the…
Leadership
Egypt is emerging as a premier destination for medical and dental tourism, driven by its blend of competitive pricing, advanced cosmetic dentistry, and rich cultural heritage. Beyond its historic landmarks, the country is gaining recognition for…
Business of Health
First-Half Performance, Challenges and Growth Potential in Egypt and the Middle East From Egypt’s Leading Private Hospital Platform to a Potential Regional Healthcare Champion Cleopatra Hospitals Group (CHG) enters the second half of 2026 from a…
Business of Health
MENA & Africa Healthcare Industry Perspective | 2026 From Local Manufacturing to Regional Pharmaceutical Leadership Among the companies shaping the next phase of the Middle East pharmaceutical industry, Jamjoom Pharma deserves particular attention. What makes Jamjoom…
Biopharma
MENA & Türkiye Biopharma and Pharmaceutical Industry | Executive Industry Perspective Coverage: 2026 The Middle East pharmaceutical industry is entering a new phase. The strategic question is no longer simply who manufactures the largest number of…
Biopharma
Saudi Healthcare Listed Market | August 2026 August 2026 has been an important month for Saudi Arabia’s listed healthcare market. Financial results, operational developments and new contracts announced during the month provide valuable insight into the…
Biopharma
A roundup of key developments in the Saudi listed healthcare sector for the month of August 2026. 📰 1. Avalon Pharma Signs Major Biosimilar Deal Middle East Pharmaceutical Industries Co. (Avalon Pharma) announced a strategic agreement…
Articles
Comment on the BNP Paribas Economic Outlook for Egypt July 2026 The BNP Paribas Economic Outlook for Egypt presents a balanced and credible assessment of the Egyptian economy, highlighting encouraging progress in macroeconomic stabilization while…
Chat with us
We typically reply within a few hours during business days.
